Skip to main content
Berry Genomics Co.,Ltd logo

Berry Genomics Co.,Ltd — Investor Relations & Filings

Ticker · 000710 ISIN · CNE000000PN7 Shenzhen Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,009 across all filing types
Latest filing 2021-11-03 Major Shareholding Noti…
Country CN China
Listing Shenzhen Stock Exchange 000710

About Berry Genomics Co.,Ltd

https://www.berrygenomics.com

Berry Genomics Co.,Ltd. is a biotechnology enterprise specializing in clinical genomics and genetic testing services. The company focuses on the research, development, and commercialization of genomic technologies for clinical applications. Its core portfolio includes non-invasive prenatal testing (NIPT), utilizing high-throughput sequencing to screen for chromosomal abnormalities. Beyond reproductive health, the company provides genomic solutions for oncology diagnostics, including early cancer screening and companion diagnostics, as well as testing for hereditary diseases. Berry Genomics leverages advanced sequencing platforms and proprietary bioinformatics pipelines to deliver precision medicine tools to healthcare providers and research institutions. The company is recognized for its role in the clinical application of Next-Generation Sequencing (NGS) and its extensive genomic databases used to enhance diagnostic accuracy and therapeutic outcomes.

Recent filings

Filing Released Lang Actions
关于持股5%以上股东减持计划实施期限届满暨实施结果的公告
Major Shareholding Notification Classification · 100% confidence The document is an announcement regarding the implementation and results of a shareholding reduction plan by a shareholder holding more than 5% of the company's shares. It details the number of shares reduced, the period of reduction, and compliance with relevant laws and regulations. There is no financial report, earnings data, or management discussion. The document is focused on notifying the market about a shareholder's reduction in holdings, which fits the category of Major Shareholding Notification (MRQ). The document length is short and it is not a report or presentation but a formal announcement of shareholding changes.
2021-11-03 Chinese
2021年第三季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2021年第三季度报告" which translates to "2021 Third Quarter Report." It contains detailed financial data including income, profit, cash flow, balance sheet items, and shareholder information for the third quarter of 2021. The presence of comprehensive financial statements and analysis for a period shorter than a full fiscal year indicates this is an Interim / Quarterly Report. The document length is substantial (15,000 characters), and it contains actual financial data, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q3 2021
2021-10-29 Chinese
2021年度业绩预告
Earnings Release Classification · 95% confidence The document is a 2021 annual performance forecast (业绩预告) for the full fiscal year 2021 (January 1 to December 31, 2021). It provides estimated financial results including net profit and earnings per share, but explicitly states that the data is preliminary and unaudited. It also explains reasons for the expected performance changes and mentions that detailed data will be disclosed in the 2021 annual report. The document is short (1571 characters) and serves as an earnings forecast rather than a full financial report. This fits the definition of an Earnings Release (ER), which is an initial announcement of quarterly or periodical financial results with key highlights only. It is not a full Annual Report (10-K) or Interim Report (IR) because it lacks comprehensive financial statements and detailed analysis. Therefore, the correct classification is Earnings Release (ER). FY 2021
2021-10-29 Chinese
独立董事关于公司控股股东及其他关联方占用公司资金、公司对外担保情况的专项说明和独立意见
Audit Report / Information Classification · 95% confidence The document is a special statement and independent opinion by the independent directors regarding the company's controlling shareholders and related parties occupying company funds, as well as the company's external guarantees. It references regulatory notices from the China Securities Regulatory Commission and Shenzhen Stock Exchange rules, indicating compliance and oversight matters. The content focuses on the verification and explanation of related party transactions and guarantees, which aligns with audit or regulatory compliance reporting rather than a full annual report or earnings release. The document is relatively short (659 characters) and contains a formal statement by independent directors, which is typical of an Audit Report / Information filing. It is not an announcement of a report publication, nor a management or board change notice. Therefore, the best classification is Audit Report / Information (AR). Q3 2021
2021-10-29 Chinese
关于全资子公司获得医疗器械注册检验报告的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (786 characters) from a company about its wholly-owned subsidiary receiving a medical device registration inspection report. It discusses the product and its potential future registration but does not contain financial data, detailed financial results, or regulatory certifications. It is an announcement of a regulatory or compliance event related to product registration, not a financial report or detailed audit. The document is not a report itself but an announcement of a regulatory milestone. Given the content and length, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-10-26 Chinese
关于持股5%以上股东减持股份的预披露公告
Major Shareholding Notification Classification · 100% confidence The document is a pre-disclosure announcement regarding the planned reduction of shareholding by a shareholder holding more than 5% of the company's shares. It details the shareholder's name, shareholding percentage, reduction plan, period, and reasons. There are no financial statements or detailed financial performance data. The document is a regulatory announcement about a major shareholding change, specifically a reduction in shares held by a significant shareholder. This fits the definition of a Major Shareholding Notification (MRQ). The document length is short and focused on shareholding changes, not a full report or earnings release.
2021-10-20 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.